At the IGTP TODAY
A new study, published in New England Journal of Medicine, has demonstrated the benefits of placing a clip on the valve instead of the usual medical treatment. The study includes the participation of Professor Antoni Bayés-Genís, principal investigator of the ICREC group and Director of the Heart Institute at Germans Trias Hospital.
_1725960548.jpg)
IGTP leading the first study in the world to prove that personalised therapies are more effective than classic drugs indicated for the treatment of this rare hormonal disease. It is based on response biomarkers that, depending on what they indicate, allow the best possible treatment to be assigned earlier. In addition to very noticeable facial and skeletal deformities, acromegaly causes severe alterations in other parts of the body. Published in The Journal of Clinical Endocrinology & Metabolism.
_1723033241.jpg)
This recognition consolidates the position of the IIS-IGTP as a reference centre in the management of biomedical research at the national level and ensures its status as an IIS for the next five years.
A study led by researchers from the Germans Trias i Pujol Research Institute (IGTP) and Institut Català d’Oncologia (ICO) analysed peripheral blood samples from patients with metastatic colorectal cancer and identified a potential biomarker indicating the effectiveness of oxaliplatin-based treatment. The research has been published in the journal Biomedicine & Pharmacotherapy.
The Psychiatry and Mental Health Research Group at IGTP, together with the ETEP (Study and Treatment of Psychotic Episodes) group at Hospital del Mar, has published a new study analysing the prescription patterns of clozapine in patients with a first psychotic episode. This study highlights the importance of broader and earlier implementation of this treatment to improve the quality of life for patients.
CMCiB celebrated its first five years of activity with a symposium dedicated to pioneering biomedical research at CosmoCaixa.
The guide offers practical recommendations for gender inclusive language in its oral, written and visual forms
DevsHealth, a leading company in artificial intelligence (AI) driven drug discovery, and the Germans Trias i Pujol Research Institute (IGTP), a public research centre in biomedical sciences, have announced a new partnership to develop new antibiotics for multi-resistant Staphylococcus aureus infections.
Cellular models used to search for new therapies for myotonic dystrophy type 1 do not usually take into account the diversity of subtypes presented by patients. A study led by researchers from IGTP has taken a step forward by developing three new models that represent this heterogeneity. The results have been published in the journal iScience.
As a strategic initiative under IGTP, GCAT (Genomes for Life) continues to make substantial contributions to public health knowledge. The latest GCAT study, conducted through the COVICAT initiative, signed by Ximena Goldberg and Rafael de Cid, sheds light on the complex interplay between genetic predispositions and environmental stressors in determining depression risk, especially during the COVID-19 lockdown. Published in Scientific Reports.
